Alivus Life Sciences Ltd vs Everest Organics Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Alivus Life Sciences Ltd is ₹ 1046 as of 13 Apr 15:30 . The P/E Ratio of Alivus Life Sciences Ltd changed from 13.4 on March 2022 to 27.2 on March 2025 . This represents a CAGR of 19.36% over 4 yearsThe P/E Ratio of Everest Organics Ltd changed from 13.4 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Alivus Life Sciences Ltd changed from ₹ 5624 crore on March 2022 to ₹ 13229 crore on March 2025 . This represents a CAGR of 23.84% over 4 yearsThe Market Cap of Everest Organics Ltd changed from ₹ 183.96 crore on March 2021 to ₹ 244.71 crore on March 2025 . This represents a CAGR of 5.87% over 5 years The revenue of Alivus Life Sciences Ltd for the Dec '25 is ₹ 686.82 crore as compare to the Sep '25 revenue of ₹ 602.7 crore. This represent the growth of 13.96% The revenue of Everest Organics Ltd for the Dec '25 is ₹ 42.84 crore as compare to the Sep '25 revenue of ₹ 51.29 crore. This represent the decline of -16.47% The ebitda of Alivus Life Sciences Ltd for the Dec '25 is ₹ 219.54 crore as compare to the Sep '25 ebitda of ₹ 193.89 crore. This represent the growth of 13.23% The ebitda of Everest Organics Ltd for the Dec '25 is ₹ 3.79 crore as compare to the Sep '25 ebitda of ₹ 5.42 crore. This represent the decline of -30.07% The net profit of Alivus Life Sciences Ltd changed from ₹ 111.48 crore to ₹ 150.26 crore over 7 quarters. This represents a CAGR of 18.60% The net profit of Everest Organics Ltd changed from ₹ -6.09 crore to ₹ 0.36 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Alivus Life Sciences Ltd changed from 61.46 % on March 2022 to 12.62 % on March 2025 . This represents a CAGR of -32.68% over 4 yearsThe Dividend Payout of Everest Organics Ltd changed from 8.75 % on March 2021 to 0 % on March 2025 . This represents a CAGR of -100.00% over 5 years .

About Alivus Life Sciences Ltd

Alivus Life Sciences Limited was initially established as 'Zorg Laboratories Private Limited', on June 23, 2011 and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra in Pune.
Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Share Purchase Agreement dated 04 July 2018 and the name of the Company was changed to Glenmark Life Sciences Private Limited' and a fresh Certificate of Incorporation dated 28 August 2018 was issued by the RoC. The name of the Company has now changed to 'Alivus Life Sciences Limited' on January 20, 2025. Nirma Limited is a Subsidiary of the Company.
The Company is engaged in the business of development, manufacture and marketing of Active Pharmaceutical Ingredients(APIs). In 2001, Glenmark Pharmaceuticals established its API business.

About Everest Organics Ltd

Everest Organics Limited was incorporated at Hyderabad in February, 1993.
It was promoted by S K Srihari Raju and S K. Chittiramabhadra Raju.
The Company is engaged in manufacturing of Active Pharmaceutical Ingredients and their intermediaries.
The Company commenced its commercial operations in the year 1993.
It set up a plant at Aroor, Andhra Pradesh to manufacture bulk drugs and formulations.

FAQs for the comparison of Alivus Life Sciences Ltd and Everest Organics Ltd

Which company has a larger market capitalization, Alivus Life Sciences Ltd or Everest Organics Ltd?

Market cap of Alivus Life Sciences Ltd is 13,190 Cr while Market cap of Everest Organics Ltd is 255 Cr

What are the key factors driving the stock performance of Alivus Life Sciences Ltd and Everest Organics Ltd?

The stock performance of Alivus Life Sciences Ltd and Everest Organics Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Alivus Life Sciences Ltd and Everest Organics Ltd?

As of May 6, 2026, the Alivus Life Sciences Ltd stock price is INR ₹1074.7. On the other hand, Everest Organics Ltd stock price is INR ₹263.0.

How do dividend payouts of Alivus Life Sciences Ltd and Everest Organics Ltd compare?

To compare the dividend payouts of Alivus Life Sciences Ltd and Everest Organics Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.